April 20, 2014 7:38 AM ET


Company Overview of Essentialis, Inc.

Company Overview

Essentialis, Inc., a pharmaceutical company, engages in the development of medicines for the treatment of cardiovascular and metabolic diseases. It offers DCCR, a once-a-day tablet formulation for patients with very high triglycerides. The company was founded in 2003 and is based in San Diego, California.

9393 Towne Centre Drive

Suite 200

San Diego, CA 92121

United States

Founded in 2003





Key Executives for Essentialis, Inc.

Chief Executive Officer
Founder and Advisor
Vice President
Director of Clinical Operations
Senior Director of Chemistry
Compensation as of Fiscal Year 2013.

Similar Private Companies By Industry

Company Name Region
Parker Hughes Cancer Center United States
Vallinex Inc. United States
Cognition Therapeutics, Inc. United States
Primus Pharmaceuticals, Inc. United States
OCT Group LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Essentialis, Inc., please visit www.essentialistherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.